Cover Image
市場調查報告書

MNuvo Research Inc.:產品平台分析

Nuvo Research Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 277760
出版日期 內容資訊 英文 44 Pages
訂單完成後即時交付
價格
Back to Top
MNuvo Research Inc.:產品平台分析 Nuvo Research Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 44 Pages
簡介

Nuvo Research Inc. 是製造外用藥及免疫疾病治療藥的製藥公司。該公司產品有治療膝關節炎用非類固醇系抗發炎藥。

本報告提供Nuvo Research Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Nuvo Research Inc.的基本資料

Nuvo Research Inc.概要

  • 主要資訊
  • 企業資料

Nuvo Research Inc.:R&D概要

  • 主要的治療範圍

Nuvo Research Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Nuvo Research Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 被申請了的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Nuvo Research Inc.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Nuvo Research Inc.:藥物簡介

  • (lidocaine + tetracaine)
  • Flexicaine
  • ropivacaine
  • triamcinolone acetonide
  • WF-10
  • alprazolam
  • lidocaine
  • ibuprofen
  • Oxo-Foam
  • risperidone
  • Small Molecules for Immunology
  • terbinafine
  • testosterone undecanoate
  • WF-10 liposomal
  • Drug 1 for Dermatological Disorders
  • Drug 2 for Dermatological Disorders

Nuvo Research Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Nuvo Research Inc.:最近的開發平台趨勢

Nuvo Research Inc.:暫停中的計劃

Nuvo Research Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07406CDB

Summary

Global Markets Direct's, 'Nuvo Research Inc. - Product Pipeline Review - 2015', provides an overview of the Nuvo Research Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nuvo Research Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Nuvo Research Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nuvo Research Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nuvo Research Inc.'s pipeline products

Reasons to buy

  • Evaluate Nuvo Research Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nuvo Research Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nuvo Research Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nuvo Research Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nuvo Research Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Nuvo Research Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Nuvo Research Inc. Snapshot
    • Nuvo Research Inc. Overview
    • Key Information
    • Key Facts
  • Nuvo Research Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Nuvo Research Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Nuvo Research Inc. - Pipeline Products Glance
    • Nuvo Research Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Nuvo Research Inc. - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Nuvo Research Inc. - Drug Profiles
    • (lidocaine hydrochloride + tetracaine hydrochloride)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Flexicaine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ropivacaine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • triamcinolone acetonide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • WF-10
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • alprazolam
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lidocaine hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ibuprofen
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Mical 1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Mical 2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Oxofoam
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • risperidone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • terbinafine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • testosterone undecanoate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • WF-10 liposomal
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Nuvo Research Inc. - Pipeline Analysis
    • Nuvo Research Inc. - Pipeline Products by Target
    • Nuvo Research Inc. - Pipeline Products by Route of Administration
    • Nuvo Research Inc. - Pipeline Products by Molecule Type
    • Nuvo Research Inc. - Pipeline Products by Mechanism of Action
  • Nuvo Research Inc. - Recent Pipeline Updates
  • Nuvo Research Inc. - Dormant Projects
  • Nuvo Research Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Nuvo Research Inc., Key Information
  • Nuvo Research Inc., Key Facts
  • Nuvo Research Inc. - Pipeline by Indication, 2015
  • Nuvo Research Inc. - Pipeline by Stage of Development, 2015
  • Nuvo Research Inc. - Monotherapy Products in Pipeline, 2015
  • Nuvo Research Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Nuvo Research Inc. - Phase II, 2015
  • Nuvo Research Inc. - Phase I, 2015
  • Nuvo Research Inc. - IND/CTA Filed, 2015
  • Nuvo Research Inc. - Preclinical, 2015
  • Nuvo Research Inc. - Pipeline by Target, 2015
  • Nuvo Research Inc. - Pipeline by Route of Administration, 2015
  • Nuvo Research Inc. - Pipeline by Molecule Type, 2015
  • Nuvo Research Inc. - Pipeline Products by Mechanism of Action, 2015
  • Nuvo Research Inc. - Recent Pipeline Updates, 2015
  • Nuvo Research Inc. - Dormant Developmental Projects,2015
  • Nuvo Research Inc., Subsidiaries

List of Figures

  • Nuvo Research Inc. - Pipeline by Top 10 Indication, 2015
  • Nuvo Research Inc. - Pipeline by Stage of Development, 2015
  • Nuvo Research Inc. - Monotherapy Products in Pipeline, 2015
  • Nuvo Research Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Nuvo Research Inc. - Pipeline by Top 10 Target, 2015
  • Nuvo Research Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Nuvo Research Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Nuvo Research Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top